Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats

Pharmacology Biochemistry and Behavior

Volumn 102, Issue 1, 2012, Pages 88-94

  Halberstadt, Adam L ^a   Buell, Mahálah R ^a   Price, Diana L ^b,d   Geyer, Mark A ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d Neuropore Therapies   (United States)

Author keywords

3,4 Methylenedioxymethamphetamine; Circadian rhythm; Habituation; Locomotor activity; Novelty

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ETRYPTAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CONTROL; CONTROLLED STUDY; DRUG EFFECT; ENVIRONMENTAL FACTOR; HABITUATION; HYPERACTIVITY; LIGHT DARK CYCLE; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

ANIMALS; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN RECEPTOR AGONISTS;

ANIMALIA; RATTUS;

EID: 84859882889     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.03.023     Document Type: Article

References (70)

1. L.M. Adams, and M.A. Geyer A proposed animal model for hallucinogens based on LSD's effects on patterns of exploration in rats Behav Neurosci 5 1985 881 900 (Pubitemid 15241516)
2. L. Adams, and M.A. Geyer Effects of DOM and DMT in a proposed animal model of hallucinogenic activity Prog Neuropsychopharmacol Biol Psychiatry 9 1985 121 132 (Pubitemid 15089220)
3. J. Akiyoshi, H. Kuranaga, K. Tsuchiyama, and H. Nagayama Circadian rhythm of serotonin receptor in rat brain Pharmacol Biochem Behav 32 1989 491 493 (Pubitemid 19139005)
4. G.B. Baker, L.E. Hiob, and W.G. Dewhurst Effects of monoamine oxidase inhibitors on release of dopamine and 5-hydroxytryptamine from rat striatum in vitro Cell Mol Biol 26 1980 183 186 (Pubitemid 10023325)
5. K.T. Ball, and G.V. Rebec Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats Psychopharmacology 81 2005 676 687 (Pubitemid 41400753)
6. 2 receptors Neuropsychopharmacology 26 2002 40 52 (Pubitemid 34075275)
7. M.H. Baumann, R.D. Clark, and R.B. Rothman Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain Pharmacol Biochem Behav 90 2008 208 217
8. J.C. Bouso, R. Doblin, M. Farré, M.A. Alcázar, and G. Gómez-Jarabo MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder J Psychoactive Drugs 40 2008 225 236
9. C.W. Bradberry, J.S. Sprouse, G.K. Aghajanian, and R.H. Roth 3,4-Methylenedioxymethamphetamine (MDMA)-induced release of endogenous serotonin from the rat dorsal raphe nucleus in vitro: effects of fluoxetine and tryptophan Neurochem Int 17 1990 509 513 (Pubitemid 20366559)
10. M. Brocco, A. Dekeyne, S. Veiga, S. Girardon, and M.J. Millan Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents Pharmacol Biochem Behav 71 2002 667 680 (Pubitemid 34219217)
11. 2-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA Psychopharmacology 173 2004 326 336 (Pubitemid 38703806)
12. C.W. Callaway, and M.A. Geyer Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist J Pharmacol Exp Ther 263 1992 318 326
13. C.W. Callaway, L.L. Wing, and M.A. Geyer Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats J Pharmacol Exp Ther 254 1990 456 464 (Pubitemid 20262081)
14. C.W. Callaway, M.P. Johnson, L.H. Gold, D.E. Nichols, and M.A. Geyer Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists Psychopharmacology 104 1991 293 301
15. N.A. Darmani The silent and selective 5-HT1A antagonist, WAY 100635, produces via an indirect mechanism, a 5-HT2A receptor-mediated behaviour in mice during the day but not at night. Short communication J Neural Transm 105 1998 635 643 (Pubitemid 28454516)
16. A.K. Evans, N. Reinders, K.A. Ashford, I.N. Christie, J.B. Wakerly, and C.A. Lowry Evidence for serotonin synthesis-dependent regulation of in vitro neuronal firing rats in the midbrain raphe complex Eur J Pharmacol 590 2008 136 149
17. P.J. Fletcher, K.M. Korth, S.R. Robinson, and G.B. Baker Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement Psychopharmacology 162 2002 282 291 (Pubitemid 34762287)
18. 1B autoreceptor in the region of the suprachiasmatic nucleus, measured by microdialysis in the conscious freely-moving rat Br J Pharmacol 131 2000 1569 1576 (Pubitemid 32056421)
19. S.E. Gartside, R. McQuade, and T. Sharp Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on 5-HT cell firing and release: comparison between dorsal and median raphe 5-HT systems Neuropharmacology 36 1997 1697 1703 (Pubitemid 28085930)
20. O. Gaytan, D. Ghelani, S. Martin, A. Swann, and N. Dafny Methylphenidate: diurnal effects on locomotor and stereotypic behavior in the rat Brain Res 777 1997 1 12 (Pubitemid 28015726)
21. O. Gaytan, A. Swann, and N. Dafny Diurnal differences in rat's motor response to amphetamine Eur J Pharmacol 345 1998 119 128 (Pubitemid 28212341)
22. M.A. Geyer, P.V. Russo, and V.L. Masten Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses Pharmacol Biochem Behav 25 1986 277 288 (Pubitemid 16040937)
23. R.A. Glennon MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethyl homolog of DOM Pharmacol Biochem Behav 46 1993 459 462
24. R.A. Glennon, M. Yousif, and G. Patrick Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs Pharmacol Biochem Behav 29 1988 443 449 (Pubitemid 19256799)
25. R.A. Glennon, R. Young, M. Dukat, and Y. Cheng Initial characterization of PMMA as a discriminative stimulus Pharmacol Biochem Behav 57 1997 151 158 (Pubitemid 27261405)
26. L.H. Gold, G.F. Koob, and M.A. Geyer Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats J Pharmacol Exp Ther 247 1988 547 555
27. E. Gouzoulis-Mayfrank, B. Thelen, E. Habermeyer, H.J. Kunert, K.A. Kovar, H. Lindenblatt, L. Hermle, M. Spitzer, and H. Sass Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study Psychopharmacology 142 1999 41 50 (Pubitemid 29196062)
28. G.A. Gudelsky, and J.F. Nash Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions J Neurochem 66 1996 243 249
29. A.L. Halberstadt, M.R. Buell, V.L. Masten, V.B. Risbrough, and M.A. Geyer Modification of the effects of 5-methoxy-N, N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors Psychopharmacology 201 2008 55 66
30. D.V. Herin, S. Liu, T. Ullrich, K.C. Rice, and K.A. Cunningham Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine Psychopharmacology 178 2005 505 513 (Pubitemid 40486991)
31. L. Hermle, M. Spitzer, D. Borchardt, K.A. Kovar, and E. Gouzoulis Psychological effects of MDE in normal subjects. Are entactogens a new class of psychoactive agents? Neuropsychopharmacology 8 1993 171 176 (Pubitemid 23051865)
32. F. Héry, E. Rouer, and J. Glowinski Daily variations of serotonin metabolism in the rat brain Brain Res 43 1972 445 465
33. P.M. Iuvone, and C. Van Hartesveldt Diurnal locomotor activity in rats: effects of hippocampal ablation and adrenalectomy Behav Biol 19 1977 228 237 (Pubitemid 8053709)
34. 2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats Neuropsychopharmacology 15 1996 116 124 (Pubitemid 26255158)
35. P.H. Kelly, P.W. Seviour, and S.D. Iversen Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum Brain Res 94 1975 507 522
36. K.M. Krebs, and M.A. Geyer Behavioral characterization of alpha-ethyltryptamine, a tryptamine derivative with MDMA-like properties in rats Psychopharmacology 113 1993 284 287 (Pubitemid 24002007)
37. M.E. Liechti, and F.X. Vollenweider The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers J Psychopharmacol 14 2000 269 274
38. M.E. Liechti, C. Baumann, A. Gamma, and F.X. Vollenweider Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram Neuropsychopharmacology 22 2000 513 521 (Pubitemid 30145619)
39. M.E. Liechti, M.R. Saur, A. Gamma, D. Hell, and F.X. Vollenweider Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT2 antagonist ketanserin in healthy humans Neuropsychopharmacology 23 2000 396 404
40. J.Q. Lu, and H. Nagayama Circadian rhythm in the response of central 5-HT1A receptors to 8-OH-DPAT in rats Psychopharmacology 123 1996 42 45
41. J.Q. Lu, and H. Nagayama Circadian rhythm in the hypothermic response to serotonin1A receptor agonist 8-OH-DPAT in rats Chronobiol Int 14 1997 267 273 (Pubitemid 27265001)
42. 1B/1D receptors J Pharmacol Exp Ther 290 1999 965 973 (Pubitemid 29400232)
43. M.J. Millan, S. Veiga, S. Girardon, and M. Brocco Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes Psychopharmacology 168 2003 397 409 (Pubitemid 37006349)
44. M.C. Mithoefer, M.T. Wagner, A.T. Mithoefer, L. Jerome, and R. Doblin The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study J Psychopharmacol 25 2011 439 452
45. S.M. Mittman, and M.A. Geyer Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol Psychopharmacology 105 1991 69 76
46. D.E. Nichols Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens J Psychoactive Drugs 18 1986 305 313 (Pubitemid 17231261)
47. D.E. Nichols, and R. Oberlender Structure-activity relationships of MDMA and related compounds: a new class of psychoactive drugs? Ann N Y Acad Sci 600 1990 613 623
48. 3H]serotonin from rat brain synaptosomes J Med Chem 25 1982 530 535 (Pubitemid 12051977)
49. D.E. Nichols, A.J. Hoffman, R.A. Oberlender, P. Jacob III, and A.T. Shulgin Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class J Med Chem 29 1986 2009 2015 (Pubitemid 16030310)
50. R. Oberlender, and D.E. Nichols Drug discrimination studies with MDMA and amphetamine Psychopharmacology 95 1988 71 76
51. R. Oberlender, and D.E. Nichols (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2- butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy- methamphetamine-like behavioral activity J Pharmacol Exp Ther 255 1990 1098 1106
52. A.C. Parrott The psychotherapeutic potential of MDMA (3,4- methylenedioxyamphetamine): an evidence-based review Psychopharmacology 191 2007 181 193 (Pubitemid 46354625)
53. M.P. Paulus, and M.A. Geyer The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity Neuropsychopharmacology 6 1992 15 31
54. M.F. Piercey, J.T. Lum, and J.R. Palmer Effects of MDMA ('Ecstasy') on firing rates of serotonergic, dopaminergic, and noradrenergic neurons in the rat Brain Res 526 1990 203 206 (Pubitemid 20307877)
55. 2C receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo Br J Pharmacol 158 2009 1477 1485
56. N.L. Rempel, C.W. Callaway, and M.A. Geyer Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release Neuropsychopharmacology 8 1993 201 211 (Pubitemid 23151387)
57. V.B. Risbrough, V.L. Masten, S. Caldwell, M.P. Paulus, M.J. Low, and M.A. Geyer Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice Neuropsychopharmacology 31 2006 2349 2358 (Pubitemid 44607051)
58. K. Sakai, and S. Crochet Differentiation of presumed serotonergic dorsal raphe neurons in relation to behavior and wake-sleep states Neuroscience 104 2001 1141 1155 (Pubitemid 32701973)
59. 1B receptor Psychopharmacology 141 1999 154 161 (Pubitemid 29200166)
60. J. Selken, and D.E. Nichols Alpha1-adrenergic receptors mediate the locomotor response to systemic administration of (+/-)-3,4- methylenedioxymethamphetamine (MDMA) in rats Pharmacol Biochem Behav 86 2007 622 630 (Pubitemid 46829314)
61. C. Singleton, and C.A. Marsden Circadian variation in the head twitch response produced by 5-methoxy-N1, N1-dimethyltryptamine and p-chloroamphetamine in the mouse Psychopharmacology 74 1981 173 176 (Pubitemid 11126550)
62. J.S. Sprouse, C.W. Bradberry, R.H. Roth, and G.K. Aghajanian MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin Eur J Pharmacol 167 1989 375 383 (Pubitemid 19216542)
63. J.S. Sprouse, C.W. Bradberry, R.H. Roth, and G.K. Aghajanian 3,4-Methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by L-tryptophan Eur J Pharmacol 178 1990 313 320 (Pubitemid 20126670)
64. M.E. Trulson, and B.L. Jacobs Raphe unit activity in freely moving cats: correlation with level of behavioral arousal Brain Res 163 1979 135 150 (Pubitemid 9111292)
65. F.X. Vollenweider, A. Gamma, M. Liechti, and T. Huber Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers Neuropsychopharmacology 19 1998 241 251 (Pubitemid 28491334)
66. F.X. Vollenweider, M.E. Liechti, A. Gamma, G. Greer, and M.A. Geyer Acute psychological and neurophysiological effects of MDMA in humans J Psychoactive Drugs 34 2002 171 184 (Pubitemid 34809986)
67. I.C. Webb, R.M. Baltazar, X. Wang, K.K. Pitchers, L.M. Coolen, and M.N. Lehman Diurnal variations in natural and drug reward, mesolimbic tyrosine hydroxylase, and clock gene expression in the male rat J Biol Rhythms 24 2009 465 476
68. N. Weiner, H.W. Clement, D. Gemsa, and W. Wesemann Circadian and seasonal rhythms of 5-HT receptor subtypes, membrane anisotropy and 5-HT release in hippocampus and cortex of the rat Neurochem Int 21 1992 7 14
69. C.H. Wichems, C.K. Hollingsworth, and B.A. Bennett Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release Brain Res 695 1995 10 18
70. L.L. Wing, G.S. Tapson, and M.A. Geyer 5HT-2 mediation of acute behavioral effects of hallucinogens in rats Psychopharmacology 100 1990 417 425 (Pubitemid 20052435)